dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorMoreno, Andreia de Haro
dc.creatorSalgado, Hérida Regina Nunes
dc.date2014-05-20T13:24:55Z
dc.date2016-10-25T16:45:34Z
dc.date2014-05-20T13:24:55Z
dc.date2016-10-25T16:45:34Z
dc.date2008-01-01
dc.date.accessioned2017-04-05T20:01:46Z
dc.date.available2017-04-05T20:01:46Z
dc.identifierAnalytical Letters. Philadelphia: Taylor & Francis Inc, v. 41, n. 12, p. 2143-2152, 2008.
dc.identifier0003-2719
dc.identifierhttp://hdl.handle.net/11449/7861
dc.identifierhttp://acervodigital.unesp.br/handle/11449/7861
dc.identifier10.1080/00032710802240818
dc.identifierWOS:000258487500002
dc.identifierhttp://dx.doi.org/10.1080/00032710802240818
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/856389
dc.descriptionA simple and reproducible spectrophotometric method for the assay of ceftazidime with neocuproin-copper(II) reagent has been developed. The procedure is based on the drug in an acidic medium, subsequent formation of yellow ternary complex in citrate buffer solution (pH 4.2), and measurement at 454 nm. Beer's law is obeyed in the range 15.0-40.0 mu g mL(-1) with correlation coefficient r(2) = 0.9995. The procedure holds good accuracy and precision when applied to the analysis of ceftazidime in powder for injection with good recovery percent ranging from 100.17 +/- 1.0 without interference from additives.
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageeng
dc.publisherTaylor & Francis Inc
dc.relationAnalytical Letters
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectceftazidime
dc.subjectpharmaceutical analysis
dc.subjectquality control
dc.subjectspectrophotometry
dc.titleSpectrophotometric determination of ceftazidime in pharmaceutical preparations using neocuproin as a complexing agent
dc.typeOtro


Este ítem pertenece a la siguiente institución